Massimiliano Colao

59 year

Health Technology

Consumer Services

Profile

Massimiliano Colao formerly worked at Amgen, Inc., as Vice President-Inflammation Sales, Abeona Therapeutics, Inc., as Chief Commercial Officer from 2018 to 2020, Alexion Pharmaceuticals, Inc., as Senior Vice President-US Commercial Operations from 2014 to 2017, and Aurinia Pharmaceuticals, Inc., as Chief Commercial Officer from 2020 to 2022.
Mr. Colao received his Masters Business Admin degree from the University of Southern California and undergraduate degree from the University of California, Los Angeles.

Former positions of Massimiliano Colao

Companies	Position	End
AURINIA PHARMACEUTICALS INC.	Corporate Officer/Principal	15/07/2022
ABEONA THERAPEUTICS INC.	Corporate Officer/Principal	01/01/2020
ALEXION PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/01/2017
AMGEN INC.	Corporate Officer/Principal	01/01/2013

See the detail of Massimiliano Colao's experience

Training of Massimiliano Colao

University of Southern California	Masters Business Admin
University of California, Los Angeles	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Massimiliano Colao's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	3
AMGEN INC.	Health Technology
ABEONA THERAPEUTICS INC.	Health Technology
AURINIA PHARMACEUTICALS INC.	Health Technology

Private companies	1
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA.	Health Technology